The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...

For a brief period in 2022, Dr. Vinay Prasad faked a concern about routine vaccines to infect unvaccinated children with ...

Lisa Jarvis The controversial appointment of oncologist Vinay Prasad — an outspoken critic of the pharmaceutical industry and U.S. health agencies — to a key role within the Food and Drug ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

In a scathing attack on the BJP, Aam Aadmi Party's (AAP) Delhi State President Saurabh Bharadwaj alleged that top bureaucrats ...

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...

Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discovery of mRNA medicines.

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

Vinay Prasad will replace Marks as CBER director Trump's budget would be "catastrophic" for federal R&D Pharma still in waiting mode after UK-US trade agreement ...